The ROC curves and AUC values of the diagnostic model. by Zhe Wu (582498)

Limma differential analysis results for IS and OSA. by Zhe Wu (582498)

Co-expression network of IS and OSA. by Zhe Wu (582498)

Histopathological appearance of the liver. by Ayça Toprak-Semiz (22582110)

Effect of KV3 modulation on PV interneuron firing frequency and on autaptic release. by Sara Hijazi (21656615)

Histopathological appearance of the heart. by Ayça Toprak-Semiz (22582110)

GSVA pathway scores for IS and OSA. by Zhe Wu (582498)

Effects of <i>MIR-96</i> on cell viability. by Zeynab Hosseinpoor (19762319)

Distance-based redundancy analysis (dbRDA) plot performed from the distance-based linear model permutation test (DistLM) that describes the aggregation of sampling stations at ever... by Francisco Flores-de-Santiago (20391063)

LASSO regression for screening candidate diagnostic biomarkers. by Zhe Wu (582498)

Summary of risk of bias. by Mohamed R. Abdelraouf (21501468)

ssGSEA is employed to analyze immune infiltration in IS and OSA. by Zhe Wu (582498)

Image 1_A rapid and naked-eye methicillin resistant Staphylococcus aureus screening method based on CRISPR/Cas12a and hybridization chain reaction.tif by Yayun Jiang (11556973)

“…<p>Methicillin-resistant Staphylococcus aureus (MRSA), a widely drug-resistant bacterium, poses a significant threat to global health. …”

Supplementary file 1_A rapid and naked-eye methicillin resistant Staphylococcus aureus screening method based on CRISPR/Cas12a and hybridization chain reaction.docx by Yayun Jiang (11556973)

“…<p>Methicillin-resistant Staphylococcus aureus (MRSA), a widely drug-resistant bacterium, poses a significant threat to global health. …”

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

“…Time to peak and recovery time were longest in the standing position (p = 0.003–0.009). HRV analyses revealed a significant decrease in AVNN from supine to sitting and standing (p = 0.003), while SDNN and LF/HF increased in upright positions (sitting and standing) (p < 0.013). …”

Fig 16 - by Zhezhe Zhang (19704587)

Fig 25 - by Zhezhe Zhang (19704587)

Fig 9 - by Zhezhe Zhang (19704587)